<VariationArchive VariationID="1456621" VariationName="NC_000017.10:g.(?_12920159)_(12920458_?)del" VariationType="Deletion" Accession="VCV001456621" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1454723" VariationID="1456621">
      <GeneList>
        <Gene Symbol="ELAC2" FullName="elaC ribonuclease Z 2" GeneID="60528" HGNC_ID="HGNC:14198" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="12991612" stop="13018027" display_start="12991612" display_stop="13018027" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="12894928" stop="12921380" display_start="12894928" display_stop="12921380" Strand="-" />
          </Location>
          <OMIM>605367</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000017.10:g.(?_12920159)_(12920458_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" innerStart="12920159" innerStop="12920458" display_start="12920159" display_stop="12920458" variantLength="300" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_12920159)_(12920458_?)del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_12920159)_(12920458_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.10:g.(?_12920159)_(12920458_?)del AND Combined oxidative phosphorylation defect type 17" Accession="RCV001951236" Version="4">
        <ClassifiedConditionList TraitSetID="11994">
          <ClassifiedCondition DB="MedGen" ID="C3809526">Combined oxidative phosphorylation defect type 17</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-09-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27769300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31045291</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11994" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18309" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation defect type 17</ElementValue>
                <XRef ID="MONDO:0014190" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 17</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD17</ElementValue>
                <XRef Type="MIM" ID="615440" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17589" />
                <XRef ID="17589" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="369913" DB="Orphanet" />
              <XRef ID="C3809526" DB="MedGen" />
              <XRef ID="MONDO:0014190" DB="MONDO" />
              <XRef Type="MIM" ID="615440" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4261850" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_018127.6_17_Deletion (exons 2-3)|MedGen:C3809526" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002238692" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27769300</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31045291</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ELAC2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 2-3 of the ELAC2 gene. This deletion is out-of-frame, and is expected to create a premature translational stop signal and result in an absent or disrupted protein product. Loss-of-function variants in ELAC2 are known to be pathogenic (PMID: 27769300, 31045291).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELAC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_12920159)_(12920458_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809526" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4261850" TraitType="Disease" MappingType="XRef" MappingValue="C3809526" MappingRef="MedGen">
        <MedGen CUI="C3809526" Name="Combined oxidative phosphorylation defect type 17" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

